Scalper1 News
Clinical software company Athenahealth (ATHN) underwhelmed Wall Street with its 2014 guidance ahead of its investor day Thursday, sending shares down 2.5% in morning trading in the stock market today, near 129. Earlier, Athenahealth stock had been down more than 6%. Late Wednesday, the company said next year’s revenue will be $725 million to $755 million, up around 25% from 2013 guidance but below consensus of $763 million. EPS was guided at 98 Scalper1 News
Scalper1 News